Monday, October 24, 2011

FDA Approves New Atrial Fibrillation Medication

by Popfossa
Article by Lynn Woods
An FDA panel has unanimously approved a new type of blood-thinning medication, Pradaxa (dabigatran etexilate) to help prevent stroke in people with atrial fibrillation. Atrial fibrillation (AF) is an irregular heartbeat in which the heart's two small upper chambers (the atria) quiver instead of beating strongly. As a result, blood isn't pumped completely out of them, and the trapped blood may pool and clot.Atrial fibrillation is dangerous because of the

heartburn symptoms

No comments:

Post a Comment